Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Kidney Dis. 2009 Jul;54(1):112-21. doi: 10.1053/j.ajkd.2008.09.023. Epub 2009 Jan 29.

Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study.

Author information

  • 1Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN, USA.

Abstract

BACKGROUND:

Antibody response to the inactivated influenza vaccine is not well described in kidney transplant recipients administered newer, but commonly used, immunosuppression medications. We hypothesized that kidney transplant recipient participants administered tacrolimus-based regimens would have decreased antibody response compared with healthy controls.

STUDY DESIGN:

Prospective cohort study of 53 kidney transplant recipients and 106 healthy control participants during the 2006-2007 influenza season. All participants received standard inactivated influenza vaccine.

SETTING & PARTICIPANTS:

Kidney transplant recipients administered tacrolimus-based regimens at a single academic medical center and healthy controls.

PREDICTOR:

Presence of kidney transplant.

OUTCOMES:

Proportion of participants achieving seroresponse (4-fold increase in antibody titer) and seroprotection (antibody titer > or = 1:32) 1 month after vaccination.

MEASUREMENTS:

Antibody titers before and 1 month after vaccination by means of hemagglutinin inhibition assays for influenza types A/H1N1, A/H3N2, and B.

RESULTS:

A smaller proportion of the transplantation group compared with the healthy control group developed the primary outcomes of seroresponse or seroprotection for all 3 influenza types at 1 month after vaccination. The response to influenza type A/H3N2 was statistically different; the transplantation group had 69% decreased odds of developing seroresponse (95% confidence interval, 0.16 to 0.62; P = 0.001) and 78% decreased odds of developing seroprotection (95% confidence interval, 0.09 to 0.53; P = 0.001) compared with healthy controls. When participants less than 6 months from the time of transplantation were considered, this group had a significantly decreased response to the vaccine compared with healthy controls.

LIMITATIONS:

Decreased sample size, potential for confounders, outcome measure used is the standard but does not give information about vaccine efficacy.

CONCLUSIONS:

Kidney transplant recipients, especially within 6 months of transplantation, had diminished antibody response to the 2006-2007 inactivated influenza vaccine.

PMID:
19185404
[PubMed - indexed for MEDLINE]
PMCID:
PMC3772511
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk